Please try another search
Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products comprising vitamins and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides specialty pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables to patients with conditions, such as diabetes, cancer, cardiovascular diseases, renal diseases, and others. The company’s product portfolio comprises vascor, acetan, covasc, crystorvas, bezartan, vytan, and vytocor; insugen and basalog one; kytron, zuhera, lebreta, trevive, and krabeva; and unihepa, ranofer, erysaa, bi-haemosol, and haemosol. The company offers its products under the Champs, Flavettes, Eye Glo, Proviton, Naturalle, and Uphamol brands. In addition, it offers property management and services; and distributes, imports, and exports chemical products. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. Duopharma Biotech Berhad was founded in 1978 and is headquartered in Kuala Lumpur, Malaysia.
Name | Age | Since | Title |
---|---|---|---|
Mohd Radzif Bin Mohd Yunus | 63 | 2018 | Non Independent Non Executive Director |
Nik Moustpha Bin Hj Nik Hassan | 68 | 2017 | Independent Non-Executive Director |
Ariff bin Abdul Shatar | 57 | 2008 | Group MD & Executive Director |
Sa’diah binti Sheikh Bakir | 70 | 2016 | Non-Independent Non-Executive Chairman |
Zaiton Binti Jamaluddin | 62 | 2016 | Independent Non Executive Director |
Razalee Bin Amin | 70 | 2016 | Independent Non-Executive Director |
Zaki Morad Bin Mohamad Zaher | 73 | 2019 | Independent Non-Executive Director |
Nik Moustpha Bin Haji Nik Hassan | 69 | 2017 | Independent Non-Executive Director |
Eisah Binti A. Rahman | 68 | 2016 | Senior Independent Non-Executive Director |
Mohd Radzif Bin Mohd Yunus | 65 | 2018 | Non Independent Non Executive Director |
Muhammad Shukri Bin Ismail | 32 | 2023 | Non Independent & Non Executive Alternate Director |
Kartini Binti Hj. Abdul Manaf | 62 | 2023 | Independent Non-Executive Director |
Mohd Haris Bin Mohd Arshad | 51 | 2024 | Non-Independent & Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review